Soligenix, Inc. Registration Statement Declared Effective
Ticker: SNGX · Form: EFFECT · Filed: 2026-04-03T00:15:04-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
Related Tickers: SOLG
TL;DR
SOLG registration statement effective 4/2/26. Ready to raise cash.
AI Summary
Soligenix, Inc. filed an EFFECT form on April 3, 2026, indicating the effectiveness of a registration statement. The effectiveness date was April 2, 2026. The filing is related to Act 33 and has file number 333-271049.
Why It Matters
This filing signifies that Soligenix, Inc.'s securities offering has met SEC requirements and can now proceed with its planned capital raise.
Risk Assessment
Risk Level: medium — Effectiveness of a registration statement is a procedural step, and the actual success of the offering and its impact on the company's stock price are subject to market conditions and investor sentiment.
Key Numbers
- 2026-04-02 — Effectiveness Date (The date the registration statement became effective.)
- 333-271049 — File Number (The SEC file number associated with this registration.)
Key Players & Entities
- Soligenix, Inc. (company) — Filer
- 0000812796 (company) — CIK number for Soligenix, Inc.
- 333-271049 (dollar_amount) — File number associated with the filing
- 2026-04-03 (date) — Acceptance date of the filing
- 2026-04-02 (date) — Effectiveness date of the registration statement
FAQ
What type of filing is this?
This is a Form EFFECT, which signifies a Notice of Effectiveness for a registration statement.
When did the registration statement become effective?
The registration statement became effective on April 2, 2026.
What is the CIK number for Soligenix, Inc.?
The CIK number for Soligenix, Inc. is 0000812796.
What is the SEC file number associated with this filing?
The SEC file number is 333-271049.
What is the primary business of Soligenix, Inc. according to the filing?
Soligenix, Inc. is in the Pharmaceutical Preparations industry (SIC 2834).
From the Filing
EDGAR Filing Documents for 9999999995-26-001056 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001056 Accepted 2026-04-03 00:15:04 Documents 1 Effectiveness Date 2026-04-02 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 598 Complete submission text file 9999999995-26-001056.txt 2028 Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200 SOLIGENIX, INC. (Filer) CIK : 0000812796 (see all company filings) EIN. : 411505029 | State of Incorp.: DE | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-271049 | Film No.: 26836683 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)